Figure 2
From: In Vitro Hematological and In Vivo Vasoactivity Assessment of Dextran Functionalized Graphene
Histamine release from activated and induced RBL-2H3cells treated with GNP-Dex (1-10 mg/ml) or dextran only (0.4 mg/ml and 4 mg/ml) formulations for 45 min.
Data are presented as mean ± SD (n = 6 per group). * = p < 0.05 between treatment groups and uninduced control.
